About Ocera | Management

Laurent Fischer   Scott Harris   Dana S. McGowan   Keith E. Anderson
Karen K. Church    Akiko Shibata    Caroline S. LaPlaca

Keith E. Anderson, Ph.D., Vice President Pharmaceutical Sciences

Dr. Anderson has more than 10 years of international experience working in the field of Pharmaceutical Sciences in Canada, USA, and Europe. He most recently held the position of Senior Director, Pharmaceutical Development at Ligand Pharmaceuticals where he was responsible for all aspects of CMC (chemistry, manufacturing and controls) for Ligand Development and Commercial products. He has had extensive experience in process and product development for small molecules and biologics covering a variety of dosage formats including parenterals, oral solid dosage forms, topicals, sustained release dosage forms, and inhaled products. Dr. Anderson’s background includes experience in managing all aspects of virtual drug product development through contract manufacturing operations from early-stage preclinical development through tech transfer and commercial process validation.